OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 35
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 57
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 57
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Comparative Effectiveness of Outpatient COVID‐19 Therapies in Solid Organ Transplant Recipients
Zachary A. Yetmar, Viengneesee Thao, David A. Helfinstine, et al.
Transplant Infectious Disease (2025)
Closed Access
Zachary A. Yetmar, Viengneesee Thao, David A. Helfinstine, et al.
Transplant Infectious Disease (2025)
Closed Access
Andrew Sulaiman, Isabella Sengsouk, Jodie L. White, et al.
Transfusion (2025)
Closed Access
Safety of COVID ‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 11
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 11
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
Bénédicte Billi, Paul Cholley, Vincent Grobost, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Bénédicte Billi, Paul Cholley, Vincent Grobost, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B‐cell depleted patients with persistent COVID ‐19
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
Single Monoclonal Antibodies Should Not Be Used for Coronavirus Disease 2019 Therapy: A Call for Antiviral Stewardship
Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 6, pp. 1404-1407
Closed Access | Times Cited: 2
Arturo Casadevall, Daniele Focosi, Liise-anne Pirofski, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 6, pp. 1404-1407
Closed Access | Times Cited: 2
COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7
What do we know about covid in immunocompromised people?
Katharine Lang
BMJ (2023), pp. p1612-p1612
Open Access | Times Cited: 7
Katharine Lang
BMJ (2023), pp. p1612-p1612
Open Access | Times Cited: 7
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 6
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 6
The value of observational registry studies for the next infectious disease emergency
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)
Taweegrit Siripongboonsitti, Nuttakant Nontawong, Kriangkrai Tawinprai, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 5
Taweegrit Siripongboonsitti, Nuttakant Nontawong, Kriangkrai Tawinprai, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 5
Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
Sonal Pannu, Michael H. Cardone, Mohankumar Doraiswamy, et al.
CHEST Critical Care (2024) Vol. 2, Iss. 2, pp. 100048-100048
Open Access | Times Cited: 1
Sonal Pannu, Michael H. Cardone, Mohankumar Doraiswamy, et al.
CHEST Critical Care (2024) Vol. 2, Iss. 2, pp. 100048-100048
Open Access | Times Cited: 1
Convalescent Plasma for Immunocompromised Patients
Shmuel Shoham
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Shmuel Shoham
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Spike and nucleocapsid antibody dynamics following SARS ‐CoV ‐2 infection and vaccination: Implications for sourcing COVID ‐19 convalescent plasma from routinely collected blood donations
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 1
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 1
Misinterpretation of Clinical Research Findings and COVID-19 Mortality
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management
Evangelos Terpos, A.R. Branagan, Ramón García‐Sánz, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 107-112
Open Access | Times Cited: 3
Evangelos Terpos, A.R. Branagan, Ramón García‐Sánz, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 107-112
Open Access | Times Cited: 3
Dual antiviral therapy in haematological patients with protracted SARS‐C oV ‐2 infection
Francesco Peracchi, Marco Merli, C. Rogati, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 6
Open Access | Times Cited: 3
Francesco Peracchi, Marco Merli, C. Rogati, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 6
Open Access | Times Cited: 3
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 3
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 3
Efficacy of Convalescent Plasma to Treat Long-Standing COVID-19 in Patients with B-Cell Depletion
Luca Tomisti, Francesca Angelotti, Mirco Lenzi, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1266-1266
Open Access | Times Cited: 2
Luca Tomisti, Francesca Angelotti, Mirco Lenzi, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1266-1266
Open Access | Times Cited: 2
Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions
Raymund R. Razonable
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 619-631
Closed Access | Times Cited: 2
Raymund R. Razonable
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 619-631
Closed Access | Times Cited: 2
